EGI Capital is a venture capital and private equity firm based in Cambridge, MA. EGI Capital provides seed capital out of the Chong De Angel Fund, an angel group subsidiary within EGI Capital, and also provides equity to later stage IT (robotics, AI, IoT, new materials, FinTech, etc.) and healthcare companies. EGI Capital is backed by five public pharmaceutical companies and ten public IT and healthcare companies from Taiwan and Mainland China. Chong De Angel Fund provides up to $2M seed stage investments in early-stage companies, while EGI Capital provides equity of $2M - $5M per company post-seed stage. EGI Capital is also actively looking for PE and M&A opportunities worldwide in the $1~5B range. EGI Capital seeks companies on a global level, though has a focus in Boston and North America East Coast-based companies.